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The effects of low and high protein diets on glomerular hyperfiltration
and systemic hypertension in Fawn-Hooded rats. M.H. de Keijzer, A.P.
Provoost, Department Pediatric Surgery, Erasmus University, Rotter-
dam, The Netherlands. Renal ablation experiments have shown that
normalization of glomerular hypertension rather than systemic hyper-
tension is crucial in the prevention or reduction of renal damage.
Restriction in dietary protein intake reduced the progression of renal
insufficiency after unilateral nephrectomy by lowering the glomerular
pressure. A high protein diet accelerates the fall in renal function after
renal ablation, but has been reported to decrease the systemic blood
pressure in SHR. This indicates that variations in protein intake may
have opposing effects on systemic and intraglomerular blood pressure.
Male rats of the Fawn-Hooded (FH) strain develop hypertension and
are characterized by glomerular hyperfiltration, culminating in focal and
segmental glomerulosclerosis, proteinuria and a reduced life span. To
substantiate the role of systemic and glomerular pressures on the renal
deterioration in FH rats, we investigated the effects of a low protein diet
(LP; 12%) and a high protein diet (HP; 36%) on renal function and
systolic blood pressure (SBP). The glomerular filtration rate (GFR) was
regularly determined as the plasma clearance of [51Cr]EDTA, while
SBP was measured by tail plethysmography:
SBP mm Hg GFR mI/mm
Week LP HP LP HP
12 163 3 (16) 157 1(17) 2.46 0.06 3.23 0.07'
20 158 3 (16) 151 2(17) 2.44 0.10 3.33 0.o7
36 158 4(15) 152 2 (17) 2.65 0.08 2.96 0.08
52 170 5(14) 156 2 (l5) 2.67 0.18 2.55 0.20
68 173 5 (14) 156 8 (l2) 2.52 0.18 1.95 0.3la
84 183 5 (12) 153 4 (6) 1.86 0.25 0.90 0.29a
100 184 11(8) 142 12 (4) 1.27 0.27 0.36 Q.l6a
Values are given as means sM; P < 0.05 versus LP diet; (N):
surviving rats
Initially, the GFR of all rats was stable and mean GFR of rats fed HP
was 30% higher than that of rats on LP. From week 36 the GFR of the
rats fed HP decreased and from then on rats were lost due to uremia. On
LP the length of the stable period nearly doubled and the rate of
decrease in GFR was less. The SBP of rats on LP was significantly
higher than that of rats on HP from week 52 onwards. Median survival
time was 80 weeks on HP and 102 weeks on LP. The LP diet most
probably limited the development of glomerular hypertension without
reducing systemic hypertension. In contrast, a HP diet reduced sys-
temic hypertension, but increased intraglomerular pressure. These
findings show that, analogous to the renal ablation model, glomerular
hypertension is responsible for the progressive glomerular injury in FH
rats. Likewise, in these rats normalization of glomerular hypertension
rather than systemic hypertension is essential to reduce renal damage.
Renal reserve capacity in acromegalic patients: Effect of treatment with
the somatostatine analogue SMS 201-995. R.P.F. Dullaart, S. Meijer,
W.J. Sluiter, H. Doorenbos, G.K. van der Hem, Department of
Internal Medicine, University Hospital Groningen, The Netherlands.
Elevated growth hormone (OH) levels as found in acromegaly, appear
to be involved in glomerular hyperfiltration. The responsible mecha-
nism and the remaining renal reserve capacity in acromegaly is un-
known. Dopamine (D) acts predominantly on the efferent and aminoac-
ids (AA) on the afferent glomerular arteriole. Therefore we assessed the
effects of D (1.5 to 2.0 zg/kgImin for 2 hr and AA (VaminN, 80 mI/hr for
20 hr) and their combined infusions (AA + D) on renal hemodynamics
in 7 patients with acromegaly (age 43 12 yr, mean so; mean 6 hr GH
levels 16 8, range 8 to 32 pg/liter). The patients were restudied after
a 3 months treatment period with the somatostatine analog SMS 201-995
(300 pg/day) (SMS) to reduce OH levels. GFR and ERPF were
determined using '25l-iothalamate and '311-hippurate, respectively. The
effects of D, AA and AA + D on GFR and ERPF are given as the
difference in % from baseline before and after SMS.
Baseline D AA AA + D
changes in % of baseline
GFR mI/mini
1.73 m2
Before SMS 132 13 11 3 5 16 19 l7
After SMS 117 l6 13 ll 14 l7 31 2l
ERPF mI/mini
1.73 m2
Before SMS 547 85 33 8 —2 18 36 23
After SMS 487 83b 35 l6 II l5 43 25
Filtration
fraction
Before SMS 0.24 0.02 0.20 0.02a 0.26 0.01 0.22 0.02
After SMS 0.25 0.02 0.21 0.02a 0.25 0.02 0.23 0.02
a Different from baseline by analysis of variance, P < 0.05.
b Decreased compared with before SMS, P < 0.05.
The present data indicate a normal response to D and an abolished
response to AA when GH is elevated. After reduction of GH by SMS,
GFR and ERPF are decreased and the response to AA is restored.
Since the response to D is not affected by SMS, the mechanism by
which D acts on renal haemodynamics is different from GH. We
conclude that the glomerular hyperfiltration in acromegaly is associated
with a maximal vasodilatation of the afferent glomerular arteriole.
Three point linkage analysis using multiple DNA polymorphic markers
in families with X-linked nephrogenic diabetes insipidus. N. Knoers,
H.v.d. Heyden, BA. v.Oost, L. Monnens, J. Willems, H.H. Ropers,
Departments of Human Genetics and Pediatrics, St. Radboud Hospi-
tal, Nijmegen, The Netherlands. Congenital nephrogenic diabetes
insipidus (NDI) is mostly an X-linked recessive disease, characterized
by polyuria, polydipsia, fever, periods of life-threatening dehydration
and failure to thrive. These clinical features are attributed to an intrinsic
defect in the distal renal tubule, which results in a failure of end-organ
response to either endogenous or exogenous vasopressin. In previous
studies we have assigned the gene locus for NDI to the distal long arm
of the human X chromosome, to band Xq28, by demonstrating tight
linkage to DXS52 and other DNA markers. However, until now the
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precise location of the disease locus could not be determined, owing to
the absence of recombination between the NDI gene and any of these
Xq28 restriction fragment length polymorphism (RFLP) markers. In
order to define the position of the NDI locus more precisely and to
generate a genetic map of the Xq28 region, we have performed
multipoint linkage analyses in 11 Dutch NDI families, employing six
cloned DNA probes corresponding to the loci F9, DXS98, DXS 134,
DXS52, CBD/CBP, and F8, all located in the Xq27-qter interval. These
studies enabled us to map the NDI gene between closely Jinked flanking
markers in the Xq28 region and to obtain the following gene order:
centromere - F9 - DXS98 - F8/CBD,CBP - DXS52/ NDI - DXSI34. This
refined localization of the NDI gene, with markers on each side of the
locus, significantly increases the accuracy of both carrier detection and
presymptomatic/prenatal diagnosis of NDI. Moreover, it should im-
prove the prospects for identiflying the fundamental gene defect under-
lying this disorder.
Renal adaptation to high potassium (K) intake serves sodium (Na)
balance rather than K balance. A.J. Rabelink, H.A. Koomans, E.J.
Dorhout Mees, Department of Nephrology, University Hospital,
Utrecht, The Netherlands. Adjustment of renal K excretion to a high K
intake is generally thought to involve an increased plasma aldosterone
(Aldo) and Na/K ATPase activity in the distal nephron. Yet, spirono-
lactone given during a high K diet causes natriuresis, but does not
decrease the high K excretion rate (Hené et al, MEM 12:165, 1986). We
surmised that the renal adaptation serves to prevent K-induced Na loss,
and thus to maintain Na balance rather than K balance. This possibility
was analyzed further, Six normal subjects were studied in balance on
25/25 mmol Na/K every 6 hr (= 100/100 mmol Na/K daily, the "control
diet"), and then on 25/100 mmol Na/K every 6 hr (= 100/400 mmol
Na/K daily, the "high K diet"). The latter diet increased (before meal-)
plasma K from 3.6 0.1 to 4.0 0.1 mmol/liter (after 3 and 17 days),
and Aldo from 348 105 to 820 155 (after 3 days) and 556 118
pmol/liter (after 17 days). K "balance" (renal excretion --80% of K
intake) was reached on the second day of the high K diet. An acute oral
K load (100 mmol) was completely excreted within 6 hr during both
diets, but induced less natriuresis during chronic K loading (42 mmol/6
hr) than during control diet (70 mmol/6 hr). After changing the high K
diet back to 100/100 mmol Na/K daily the K excretion fell sharply from
375 to 115 mmol during the first 24 hr, but there was considerable Na
retention (110 mmol in 3 days). After a 2-week washout period the
subjects once again took the control diet, and then switched to Na
loading (100/25 mmol Na/K every 6 hr). Again balance was reached on
the second day (Na excretion 100% of intake). On day 4 Aldo had
decreased to 190 pmol/liter. A 100 mmol K load was again excreted
within 6 hr, but now caused an enormous Na excretion (224 mmol/6 hr).
Based on these data we propose revision of the prevailing concept of
renal adaptation to K-loading as follows. Single or repeated K loads
cause a rise in distal Na delivery (rise in plasma K probably lowers
reabsorption in Henle's loop). The resulting Na excretion is soon
reduced by increased Na reabsorption in the distal nephron, caused by
Aldo (early) and cellular adaptation (late). Abrupt discontinuation of K
loading reveals the true nature of this adaptation: increased Na reab-
sorption but not K secretion persists for some days. A K load probably
also causes increased distal K delivery by the same mechanism by
which it causes increased Na delivery. This K is excreted, independent
of Aldo or distal tubule adaptation. This explains why K balance is
regained immediately after stopping a high K intake, and also why
spironolactone given during K loading causes Na loss but no K
retention.
Acute decreases of proteinuria during alternate-day prednisone therapy
in patients with membranous glomerulonephritis J.F.M. Wetzels, A.J.
Hoitsma, R.A.P. Koene, Division of Nephrology, University Hospital,
Nmegen, The Netherlands. Treatment of patients with membranous
glomerulonephritis (MG) with high dose prednisone (P) on alternate
days results in a decreased protein excretion rate on non-prednisone
days, which is not related to any therapeutic effect of P. We have
studied this phenomenon in more detail in 14 patients (11 M, 3 F) with
MG. Mean age SD of the patients was 47 14 years, mean
endogenous creatinine clearance 94 35 mI/mm and mean proteinuria
10.1 6.7 g/24 hr. Glomerular filtration rate (GFR, inulin clearance),
effective renal plasma flow (ERPF, PAll clearance), and proteinuria
were measured at baseline (B), and six days after start of alternate - day
P treatment, on a NP day (NP3, 24 to 28 hr after the last dose of
prednisone). Proteinuria decreased from 7.7 1.9 mg/mm (B) to 4.9
1.5 mg/mm (NP3; mean SEM, P <0.01; percentage of decrease: 45
8%). The decrease of proteinuria was correlated with baseline GFR (r
0.75; P < 0.01). GFR and ERPF did not change significantly, however,
filtration fraction decreased significantly by 7 2% from 0.144 0.008
(B) to 0.135 0.009 (NP3; P < 0.05). In nine patients we measured
urinary excretion of albumin, IgG, and f32-microglobulin (/32m). Urinary
excretion of all these proteins decreased significantly, excretion of
albumin from 5.62 1.49 to 3.77 1.07 mg/mm, excretion of IgG from
0.40 0.18 to 0.17 0.08 mg/mm, and excretion of f32m from 10.5 7.4
to 6.4 4.7 tg/min. Selectivity index of the proteinuria tended to be
lower on NP3. We conclude that proteinuria is decreased on NP days in
patients with MG treated with alternate day steroids. In view of the
known permissive effect of corticosteroids on proteinuria, this decrease
of proteinuria may be related to a depressed endogenous cortisol
production on NP3 (serum cortisol B: 0.27 0.04 mmol/liter; NP3: 0.10
0.02 mmol/liter; P < 0.01). Mechanisms which are probably involved
in this decrease of proteinuria are a decrease of intraglomerular
capillary pressure, as reflected by the decreased filtration fraction, and
a change in glomerular permselectivity characteristics, as indicated by
the magnitude of the effect and the change in the selectivity index of the
proteinuria.
Clinical study of the effIcacy and tolerance of recombinant human
erythropoietin after intraperitoneal administration in patients treated
with continuous ambulatory peritoneal dialysis. L.A .M. Frenken, P.J. W.
Coppens, R.G.W.L. Tiggeler, D.G. StruUk, R.T. Krediet, R.A.P.
Koene, Departments of Medicine, Divisions of Nephrology, University
Hospital, Nzjmegcn, and Academic Medical Centre, Amsterdam, The
Netherlands. Intravenous (i.v.) administration of recombinant human
erythropoietin (r-HuEPO) is an effective treatment for the anemia of
chronic kidney failure in hemodialysis patients as well as in pre-dialysis
patients. The reported bioavailability of r-HuEPO is limited to 20%
after subcutaneous (s.c.) and to only 5% after intraperitoneal (i.p.)
administration when compared to i.v. administration. On the basis of
these data one might conclude that i.p. administration is not an effective
therapeutic approach. As part of a two center study of the efficacy and
tolerance of the s.c. and i.p. administration of r-HuEPO, patients on
continuous ambulatory peritoneal dialysis (CAPD) injected r-HuEPO
(100 U/kg) in their dialysis bag three times weekly. Dialysis volume was
one liter and the glucose concentration was 1.5%. The dwell times were
10 to 12 hours during the night. Three patients (1, 3, and 5) needed
regular blood transfusions before r-HuEPO therapy. The results ob-
tained in the first five patients after 8 to 10 weeks of treatment
demonstrate that r-HuEPO was effective in each patient.
Patient
1 2 3 4 5
Hemoglobin mmol/liter
Pre-study
After 10 weeks
3.3
5.3
5.1
7.1
3.3
4.7
4.6
7.2a
3.3
7.3
a 8 weeks.
An increase in reticulocyte counts was seen within one week of the start
of the treatment. Platelet counts did not change, No episode of
peritonitis has occurred so far. Our results show that standard descrip-
tive pharmacokinetics are not the appropriate model to predict the
biological response to r-HuEPO. Intraperitoneal administration of
r-HuEPO appears to be an convenient alternative in CAPD patients.
More studies are needed to identify the precise indications and the
optimal dosage schedule for this treatment modality.
Relation between fluid balance and frequency of hypotension during
hemodialysis (HD) and hemofiltration (HF). P.M.J.M. de Vries, P.M.
Kouw, A. SoIf, B. Schuenemann, E. Quellhorst, P.L. Oe and A.J.M.
Donker, Department of Internal Medicine, Free University Hospital,
Amsterdam, The Netherlands and Nephrologisches Zentrum Nieders-
achsen, Hannover, Mdnden, Federal Republic of Germany. Hypoten-
sion is a frequent complication of extracorporeal renal replacement
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therapy. An insufficient replacement of the ultrafiltrated plasma volume
by tissue water is one of the important causes of this complication. In
order to picture the fluid balance and its effect on blood pressure during
HD and HF 15 patients in each group were studied. Extracellular (EFV)
and intracellular fluid volume (IFV) were measured continuously by
means of a non-invasive conductivity method using four skin electrodes
around the leg. Blood volume (BV) was determined before and after
treatment by erythrocyte counts. Blood pressure and pulse were
recorded throughout treatment. BV decrease during HD significantly
exceeded the change during HF (14.0 vs. 10.8%). The refill was 81% and
86% of ultrafiltration volume, respectively. The refill fluid during HD
only originated from the EFV; during HF IFV and EFV recruitment
occurred. Coupled with this the frequency of hypotension and cramps
in the HF group was only half of that in the HD patients. Inherent to the
used HF modality a sodium and an ultrafiltration profile were used,
resulting in a higher plasma sodium level after treatment than after HD.
Applying these profiles to HD patients gave rise to a significant
decrease of the mentioned BY change (11.4 vs. 14.0%). Refill increased
and the tissue fluid loss involved both EFV and IFY. The frequency of
hypotension and cramps diminished. It can be concluded that the
described combination of measurements visualizes the total fluid bal-
ance of the patient during renal replacement therapy. Hemofiltration
seems to be more physiological than hemodialysis, mainly as a cause of
a different sodium and ultrafiltration profile.
The influence of fluid removal during hemodialysis on macro- and skin
microcirculation. K.M.L. Leunissen, B. W. van den Berg, E.C. Cheriex,
R.S. Reneman, D.W. Slaaf, J.P. van Hooff, Department of Nephrol-
ogy, Cardiology and Physiology, University Hospital, Maastricht, The
Netherlands. Changes of macro- and microcirculation during hemodi-
alysis and fluid removal are probably dependent on ultimate fluid status,
and on the efficacy of various regulation mechanisms like the catechol-
amines. This was studied in 20 chronic dialysis patients. Pre- and
postdialysis stroke volume (SV), mean arterial pressure (MAP), heart
rate (HR) and systemic vascular resistance (SVR) were measured.
Furthermore microcirculation was studied by Laser doppler flow (LD)
and by intravital microscopy of finger nailfold, measuring red blood cell
velocity (RBCv) and capillary density (CD). Pre- and postdialysis
noradrenaline (NA) and adrenaline (A) were measured. Nine patients
proved to be hypovolemic after dialysis (gr I) and II patients proved to
be normovolemic or less hypervolemic (gr II) according to the vena
cava inferior parameters. There was a significant decrease in MAP and
SV in gr I and an increase of HR, whereas in gr II there was only a
decrease in MAP. SVR did not change in both groups. NA decreased
although not significantly in both groups, whereas in gr I A increased
significantly. There was a significant decrease of skin perfusion in gr 1,
whereas in gr II there was a significant increase (table). CD increased
significantly in gr LI after reaching normovolemia.
Results:
SV
ml
MAP
mm Hg
RBCv
mIsec
LD
Au
CD
cap/screen
NA A
mmol/liter
Gr I
—0.3 —2.0 +0.13
GrIl —4,9 —8.7 +184** +17** —0.9 —0.01
Underhydration was leading to microcirculatory changes on basis of a
decrease of SV and an increase of A, while ultrafiltration leading to a
normal fluid status induces microcirculatory changes, which are related
to arterial and venous pressure changes and their effect on the myogenic
response as a local autoregulatory effect.
Fish oil and renal function in cyclosporin-treated psoriasis patients.
H.J.G. Bib, T.J. Stoof, M.J. Korstanje, E.F.I. Comans, A.J.M.
Donker, Department of Internal Medicine and Dermatology, Free
University Hospital, Amsterdam and Department of Dermatology,
University Hospital, Maastricht, The Netherlands. As part of a larger
multicenter trial to test the efficacy, safety and tolerability of cyclo-
sporine (CsA) for induction of remission and remission maintenance in
severe, recalcitrant plaque form psoriasis, 24 patients were randomly
allocated in one of three groups and received either 2.5 or 5 mg/kg body
weight CsA, or 5 mg/kg body weight CsA combined with 6 gram
eicosapentenoic acid (EPA, C20:5 omega-3) and docosahexenoic acid
(DHA, C22:6 omega-3) daily during three months. After matching
patients for whole blood trough levels, 13 patients were included in the
analysis who received CsA alone (CsA group) and 7 patients who
received a combination of CsA and fish oil. Before and after three
months of CsA therapy GFR and ERPF were measured, using the
clearances of '251-thalamate and '311-hippuran, respectively, and ex-
pressed as mI/mm/I .73 m2. Total renal vascular resistance (TRVR) was
calculated using the formula (MAP/RBF)*80 and expressed as
dynes s/cm5. Differences between baseline and 12 week measure-
ments were expressed as the percentage change from baseline values.
CsA group CsA/EPA + DHA group P
GFR —18.0 9.6% —8.7 6.8% <0.05
ERPF —10.6 8.9% —1.2 5.7% <0.05
TRVR + 19.8 14.5% —1.8 5.9% <0.01
mean SD, Mann-Whitney U-test.
Whereas in the CsA group GFR and ERPF decreased and TRVR
increased (all changes P < 0.01, paired two-tailed Wilcoxon), in the
CsA/EPA + DHA-group only GFR decreased (P < 0.05), and ERPF
and TRVR remained unchanged. The results of this pilot study suggest
that fish oil can reduce CsA-associated renal dysfunction in psoriasis
patients.
The effects of fenoldopam and metoclopramide on renal function in
normal man. A.R.J. Girbes, A.J. Smit, S. Meijer, W.D. Reitsma,
Department of Medicine, University Hospital, Groningen, The Neth-
erlands. The effects of fenoldopam, a selective DAI dopamine agonist
and of the aselective dopamine antagonist metoclopramide on blood
pressure (BP), sodium excretion and renal hemodynamics were inves-
tigated in 10 healthy volunteers. During the first study day, a control
study was performed with only infusion of vehiculum. On the second
study day after 2 baseline values, fenoldopam was infused in increasing
doses ranging from 0.05 to 0.50 g/min/kg. On the third study day the
latter procedure was repeated; however, metoclopramide was infused
after determining baseline values, before and during fenoldopam ad-
ministration. Glomerular filtration rate (GFR) and effective renal
plasma flow (ERPF) were measured simultaneously using '251-iothala-
mate and lSIlhippurate, respectively. During fenoldopam infusion the
diastolic pressure significantly fell 9 mm Hg, and the systolic pressure
tended to increase non-significantly 5 mm Hg. Metoclopramide abol-
ished fenoldopam induced changes. ERPF rose for all doses during
fenoldopam with a maximal increase of 36% and was not influenced by
metoclopramide infusion. GFR remained unchanged during all study
days. Fenoldopam induced a moderate but significant increase in
sodium excretion compared to the control study. Metoclopramide
abolished this fenoldopam induced increase. A marked rise of PRA
during fenoldopam infusion was noted, which was blunted during
metoclopramide. Aldosterone rose significantly during fenoldopam
infusion. Metoctopramide induced an outspoken increase of aldoste-
rone, sustained, but blunted, during subsequent fenoldopam adminis-
tration. We conclude that fenoldopam induces natriuresis by direct
stimulation of DAI dopamine receptors in the proximal tubule. These
effects are (partially) counteracted by rise of PRA and subsequently of
aldosterone. The rise in PRA is probably not only caused by the
fenoldopam induced fall in blood pressure, but also due to direct DAI
dopamine stimulation. Subsequent stimulation of aldosterone secretion,
which is inhibited by DA2 dopamine stimulation, is thus not inhibited
by a selective DAI dopamine agonist as fenoldopam.
Acute renal failure in endotoxin shock is not caused by hypoperfusion
alone. A.A. van Lambalgen, A.A. van Kraats, G.C. van den Bos, L.G.
Thijs, A.J.M. Donker, Laboratory for Physiology and Department of
internal Medicine, Free University, Amsterdam, The Netherlands.
Septic shock is often complicated by renal failure. This may be due to
renal hypoperfusion or to a renal effect of endotoxin, the pathogenetic
factor in septic shock. We therefore studied in anesthetized rats
(Nembutal) the effect of endotoxin (E. coli, 10 mg/kg for 60 mm) on
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renal blood flow and function (ES-group, N = 15). In a second group
(BS-group, N = 10) a balloon was inflated in the vena cava (below renal
vein) to cause comparable decreases in cardiac output and renal blood
flow as in ES-group. A third group served as control (C-group, N = 20).
We measured mean arterial (MAP) and central venous (CVP) pressure,
cardiac output (CO; thermodilution), serum lactate and creatinine
levels. At t = 0 infusion of endotoxin (ES-group) or saline (C- and
BS-group) was started; at t = 30 mm we inflated the balloon in the
BS-group. To measure glomerular filtration rate (GFR) and renal
plasma flow (ERPF) we injected '251-thalamate (lOT) and '311-hippuran
(0TH) at t = 90 mm when cardiac output was low and serum lactate high
(indicative for shock). Experiments ended at t = 135 mm. lOT and 0111
concentration were measured in blood samples (N = 6, over 45 mm);
GFR and ERPF were calculated from biexponential disappearance
curves. At the end of the experiments CO had decreased to the same
extent in the ES- and BS-groups (to 55 23 vs. 63 11%, NS); lactate
and creatinjne concentration had more increased in the ES- than in the
BS-group (to 1260 240 vs. 640 200%, and to 249 45 vs. 158
20%, respectively, P < 0.05). In control rats ERPF and GFR were 3.06
1.36 and 0.80 0.24 ml/min 100 g body wt, respectively. ERPF was
slightly lower (0.70 0.63 vs. 1.05 0.76 mI/mm 100 g body wt, NS)
and GFR higher (0.42 0.51 vs. 0.33 0.20 ml/min 100 g body
weight, NS) in the BS- than in the ES-group. Filtration fraction was
comparable in the C- and E-group (C:0.30 0.10 and ES:0.36 0.13),
but had increased in the BS-group (0.79 0.50, P < 0.05). Renal
function is thus more affected in the ES- than in the BS-group so that
hypoperfusion is not the only cause for the acute renal failure during
endotoxin shock.
Anticardiolipin antibodies associated with dementia, renal insufficiency
and unique renal immunopathological lesions. A clinico-pathological
entity. P.J.C. van Breda Vriesman, W. Grave, K. Leunissen, Depart-
ment of Immunology, University of Limburg, Maastricht, The Nether-
lands. Anticardiolipin antibodies are associated with peripheral arterial
and venous thrombosis, cerebral infarctions, recurrent abortions or
SLE. We now describe three patients between 50 and 57 years of age
who all presented first to the neurologist with dementia (2 x) or lacunair
cerebral infarction (lx) and developed renal failure subsequently;
dementia preceeded renal failure by several years. All three patients
had high titers of anticardiolipin antibodies (IgG 2x, 1gM lx) but
showed no clinical or laboratory (no rheumatoid factor, no autoanti-
bodies to SSB, SSA, Sm, RNP or histon) evidence of SLE. Renal
biopsies showed aneurysmatic dilatation of the afferent arterioles with
local thrombosis and recanalization as the main lesion in two patients in
the absence of diffuse intravascular coagulation serologically. In both
biopsies Ig and C were deposited in a finely granular pattern along side
of the endothelial cells of afferent arterioles and along the glomerular
capillaries in an interrupted linear, finely granular pattern in the absence
of glomerular (inflammatory) proliferative or exsudative lesions. Anti-
GBM antibodies were not demonstrable, Ultrastructural analysis re-
vealed some scattered electron-dense deposits subendothelialy in one
biopsy but no such complexes were seen in the other. Plasmapheresis
and immunosuppressive therapy resulted in amelioration of cerebral
and renal disease in the one patient thus treated. We suggest that the
disease is caused by an autoimmune reaction to endothelial associated
antigens, which clinically at any rate appear to be organ specific.
Chiorambucil in steroid-resistant idiopathic membranous glomerulone-
phritis. J.F.M. Wetzels, A.J. Hoitsma, R.A.P. Koene, and the study
group, Division of Nephrology, University Hospital, Nzjmegen, The
Netherlands. We have studied the effects of chlorambucil (C) in eight
patients with idiopathic membranous glomerulonephritis, who had been
treated with high dose prednisone (P) for at least three months, but
showed persisting nephrotic syndrome and/or deteriorating renal func-
tion. All were men, their mean age was 48 years (range 17 to 62 yr). C
was given in a dose of 0.2 mg/kg/day in three periods of four weeks,
separated by two week intervals during which the patients were treated
with P in a dose of 125 mg on alternate days. All patients were followed
for at least 24 months. For the whole group of patients the rise of serum
creatinine was interrupted, proteinuria decreased and serum albumin
increased after start of the chlorambucil treatment (Table).
—12 0 6 24
months
Serum creatinine 136 (46) 203 (135) 176 (85) 222 (126)
mol/liter
Serum albumin 30 (8) 28 (9) 35 (7) 35 (7)
giliter
Proteinuria 12.4 (4.8) 10.3 (5.5) 44 (33) 6.0 (3.6)
g/24 hr
Values are given as mean (± SD). P < 0.05 compared to values at
start of treatment [=0 months].
However, these beneficial effects were most prominent at six months
and were not sustained in all patients. In two patients who entered the
study with stable renal function, this remained unchanged. Six patients
entered the study with evidence of deteriorating renal function. In five
renal function improved or stabilized, however, this response was
sustained in only three. Side effects of chlorambucil treatment were
anorexia and nausea (N = 3), itching (N = 2), and exanthema (N = I).
Furthermore, in all but one patient the dosage of chlorambucil had to be
reduced because of leuco- and thrombocytopenia. We conclude that
chlorambucil may have beneficial effects in some patients with mem-
branous glomerulonephritis who did not respond to prior treatment with
corticosteroids.
Effects of platelets and heparin on rat mesangial cell proliferation in
vivo. W.M. Bagchus, M.F. Jeunink, J.D. Elema, Department of Pa-
thology, University of Groningen, The Netherlands. Injection of mono-
clonal (MCA) anti-Thy.l antibodies in the rat causes a complement-
dependent mesangial cell lysis, followed by proliferation of mesangial
cells. Platelet aggregates are conspicuous in afflicted glomeruli. Plate-
lets and heparin have been reported to influence mesangial cell prolif-
eration. We studied the effects of platelet depletion and heparin
treatment on mesangial proliferation. Three groups of male Wistar rats
received anti-Thy.l (500 tg/l00 g body wt). Group A rats received no
further treatment. Group B rats were chronically depleted for platelets
(< 2%) by daily injections with the anti-rat platelet MCA PL.I. Group
C rats received 25 U/tOO g body wt heparin every 12 hours, leading to
a 4 times increased clotting time. Of each group 6 rats were sacrificed
after 3 and 6 days. One hour before sacrifice they were i.p. injected with
the thymidine analog BrdU to measure DNA synthesis. Kidneys were
removed and either snap-frozen or fixed in formalin. Indirect immuno-
histology on frozen kidney sections was performed with an MCA
against BrdU, and the positive cells per glomerular cross-section (gcs)
were counted by light microscopy. Mesangial hypercellularity was
scored by light microscopy on PAS-stained plastic embedded kidney
sections.
BrdU+/gcs Hypercellularity index
d3 d6 d3 d6
Group A 2.03 0.52 1.34 0.30 0.47 0.39 1.83 0.20
Group B 1.64 0.52 1.10 0.34 0.33 0.15 1.00 0.34a
Group C 1.26 0.31a 1.34 0.39 0.28 0.10 1.14 0.59
a p < 0.025 vs. group A by ANOVA
In all groups the number of BrdU positive cells had significantly
increased compared with control rats (0.23 0.05). Although in rats
from group B glomerular platelet aggregates were totally absent, cell
proliferation was only slightly reduced, leading to some diminishment
of glomerular hypercellularity at day 6. Heparin also reduced the
number of proliferating cells (at day 3) and led to some diminishment of
overall hypercellularity. We conclude that both platelet depletion as
well as heparin addition moderately decrease mesangial cell prolifera-
tion and hypercellularity.
Amino acid-induced natriuresis. P.M. ter Wee, S. Meijer, A.J.M.
Donker, Free University Hospital, Amsterdam, and State University
Hospital Groningen, The Netherlands. To investigate whether admin-
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istration of amino acids (AA) can induce natriuresis we have studied the
effect of AA on sodium excretion, GFR and effective renal plasma flow
(ERPF) in 10 healthy volunteers. With a constant infusion method three
2-hr clearances of '251-thalamate and '311-hippurate were calculated to
measure GFR and ERPF after an equilibration period of 1½ hr. The
studies were performed on two separate days with an interval of one
week. The AA-solution used was VaminRN which was made iso-
osmotic to plasma by the substitution of aquadest. On the first study
day 5% glucose, to which sodium (Na) and potassium were added to
get an equimolar solution compared with the AA-solution, was infused
at a rate of 300 mI/hr. On the second study day the AA-solution (300
ml/hr) was infused. Before each study the subjects fasted for 8 hours. At
the beginning of each study 300 ml tap water was given and during the
study the subjects were in supine position. During the test periods,
there was no difference in serum Na on the two study days. Serum
creatinine was significantly lower during the infusion of the AA-solution
(84 vs. 79 mol/liter). As can be seen in the Table, GFR, ERPF, Na
excretion, fractional Na excretion, Ca and fractional Ca in-
creased during the infusion of the AA-solution.
GFR ERPF Na FENa* Ca FEa*c
mI/mm /1.73 m2 ,umol/mm % tmol1mm %
BL 106 485 163.4 0.8 3.62 1.1
AA 113b 2l9.7a l.la 686b 21b
a P < 0.05 and b P < 0.01 vs. baseline (BL); median values.
Thus, it is concluded that infusion of amino acids can induce natriure-
sis. Since the fractional excretions of Na and Ca increased it is also
concluded that this natriuresis at least in part is based on an effect
(directly or indirectly) of amino acids on the proximal tubule. The
observation also indicates that administration of amino acids during
total parenteral nutrition might have a marked effect on sodium excre-
tion, thus inducing a negative sodium balance.
Influence of angiotensin converting enzyme inhibition on the natriuretic
effect of the calcium antagonist felodipine. H. W. van Hamersvelt, J.F.M.
Wetzels, H.J. Kioke, F.Th.M. Huysmans, R.A.P. Koene, Department
of Nephrology, University of Njjmegen, The Netherlands. The dihy-
dropyridine calcium antagonist felodipine (F) has a distinct natriuretic
effect. We have previously demonstrated that F prevents sodium
retention induced by exogenous angiotensin H (All). Interaction of F
with endogenous All could be responsible for the natriuretic effect of F.
In a randomized, double blind study, a 200 mm infusion with F or
placebo (P1) was given to 12 healthy volunteers who had been treated
for one week with the angiotensin converting enzyme (ACE) inhibitor,
ramipril (R), or placebo (P0). On R, ACE activity was reduced by 89
1%. Every 40 mm, blood pressure (Dinamap), ERPF (PAH clearance),
GFR (inulin clearance), fractional sodium (FENa) and lithium (FELi)
excretion, free water clearance (FEH2O), and plasma drug levels were
measured. Means (± SEM) of FENa, mean arterial pressure (MAP) and
renal vascular resistance (RVR) before (basal) and during infusion (mO
are given in the Table.
FENa
%
MAP
mmHg
RVR
U
F + P0 basal
inf
0.7 0.12.4 O.3 88 2a.b82 2 86 6a.b68 4
F + R basal
inf
0.6 0.11.8 o.3 83 279 2a 69 459 4
P1+R basal
inf
0.8±0.1
1.0±0.1
83±2
83±2
68±4
72±4
a P <0.01 p, + R b P <0.01 vs. F + R; C 0.05 <P <0.10 vs.
F + R. Basal values and, during inf, changes from baseline tested.
No significant changes were observed in GFR and filtration fraction.
Both after R and P0, F induced a rise in FELi and FEH2O, suggesting
inhibition of sodium reabsorption in the proximal tubule. Plasma drug
levels of F and R during combined treatment were comparable to levels
during monotherapy. We conclude that natriuretic, diuretic and hemo-
dynamic effects of F are not abolished by pretreatment with an ACE
inhibitor. Therefore, other mechanisms than interference with endoge-
nous All are involved in the natriuretic effect of F.
Effects of sodium (Na) intake on hemodynamic and tubular response to
furosemide (F) in man. J.J. Beutler, W.H. Boer, E.J. Dorhout Mees,
Department of Nephrology and Hypertension, University Hospital,
Utrechi, The Netherlands. The renal hemodynamic and tubular adap-
tations to dietary Na restriction have been identified, but not those
determining the blunted natriuresis to F during a low Na intake. To
investigate this, we performed clearance studies during maximal water
diuresis in 7 healthy humans on a high (200 mmol/day, HS) and low (10
mmollday, LS) Na intake. F was given as 40 mg bolus and 20 mg/hour
continuous infusion. According to Bartoli, the maximal urine flow
(Vmax) during F administration is a quantitative index of distal delivery
of Na and H20, and therefore the following calculations can be made:
filtered Na load (FLNa) = GFR x plasma Na, distal Na delivery (DDNa)
= V >< plasma Na, proximal Na reabsorption (PRNa) = FLNa —
DDNa, distal Na reabsorption (DRNa) = DDNa — UNaV. Additionally,
we compared to the lithium clearance (CLI), another alleged
quantitative index of distal delivery. Results are presented as mean
SD. Na restriction reduced body weight by 1.6 kg and PRA rose from
219 118 to 746 351 fmol/liter . sec.
HS LS P
FLNa mmol/min 17.4 1.8 16.4 2.2 0.07
PRNa mmol/min lO.7 1.4 10.2 1.7 NS
DDNa mmol/min 6.6 0.8 6.1 0.8 <0.01
DRNa mmol/min 1.7 0.3 1.9 0.3 NS
UNaV mmo//min 4.9 0.7 4.2 0.7 <0.01
UKV jtmol/min 351 58 402 235 NS
CLI exceeded Vmax, both on the HS (65 5 and 47 5 mI/mm,
respectively) and on the LS (67 8 and 45 5 mI/mm, respectively).
Conclusions: (I) Na restriction only slightly reduced the natriuretic
response to F; (2) the latter was caused by a fall in DDNa, which was
almost exclusively due to a lower FLNa; (3) DRNa as well as K excretion
were not significantly increased during LS; (4) CLI markedly exceeded
Vmax. This raises doubt about the validity of CLI as a quantitative index
of fluid delivery from the proximal tubules.
Triamterene increases lithium excretion in healthy subjects: Evidence
for lithium transport in the cortical collecting tubule. J.D. v Bergeyk,
J.F.M. Wetzels, F.Th.M. Huysmans, A.J. Hoitsma, R.A.P. Koene,
Department of Medicine, Division of Nephrology, University Hospital,
N,jmegen, The Netherlands. To elucidate the possibility of lithium
transport beyond the proximal tubule, we have studied the effects on
lithium excretion of triamterene, a potassium sparing diuretic, exclu-
sively acting in the cortical collecting tubule. Eight young and healthy
volunteers were studied during water diuresis at two occasions. After
obtaining baseline values, triamterene (100 mg orally) or placebo were
randomly administered and measurements continued for four hours.
Creatinine clearance (Car) was used as marker of glomerular filtration
rate, and phosphate excretion was used as an additional marker of
proximal sodium transport. Baseline values of Car, urine flow, and
electrolyte excretion were not different. Triamterene had a clear
natriuretic effect ceiling in the second period (60 to 120 mm) after
administration of the drug. Values of Car, potassium clearance (CK) and
fractional excretion of sodium (FENa), lithium (FELJ, and phosphate
(FEPH) for this period are given in the Table.
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Ccr FENa FEL FEPH CK
mI/mm % mi/mm
Placebo 136 6 0.74 0.08 21.2 1.3 9.8 1.3 11.9 3.6
Triam- 123 a 1.73 024b 27.5 15b 9,4 1.5 2.5 Ø7
terene
Values are given as means SEM. P 0.05; b P0,01
As expected, triamterene acutely increased sodium excretion and
lowered potassium excretion. The increased sodium excretion was
accompanied by an increase of lithium excretion, whereas phosphate
excretion remained unchanged. From this we ncIude that lithium is
reabsorbed in the cortical collecting tubule, nIiting its value as a
marker of proximal tubular sodium reabsorptk.
Continuous arterio-venous hemodiafiltration: A mathematical model of
solute transport. H.H. Vincent, E. Akcahuseymn, W.A. v Duyl, F.J. v
Ittersum, G.J. Wenting, M.A.D.H. Schalekamp, Department of Inter-
nal Medicine land Department of Biomedical Physics and Technology,
Erasmus University, Rotterdam, The Netherlands. Continuous arterio-
venous hemofiltration (CAVH) is characterized by the use of a small
surface, highly permeable hemofilter, and spontaneous blood flow and
spontaneous ultrafiltration. With CAVH solute clearance is limited due
to the gradual loss of membrane permeability and filtrate production. In
CAVHD solute clearance is increased by combining CAVH with
continuous slow countercurrent dialysis. Presently, there are no pub-
lished data on the determinants of solute transport in CAVHD. There-
fore we developed a mathematical model of convective and diffusive
mass transfer in CAVHD, and analyzed our data on solute clearance
under several clinical and technical conditions. Membrane characteris-
tics and filtrate production were taken to be constant over the filter
length. However, the interaction of convection and diffusion and the
influence of protein boundary layer formation, as reflected in a fall in
the in vivo membrane index, and of clotting, as reflected in an increased
blood path resistance, were taken into account. Blood and dialysate
solute concentrations were calculated as a function of filter length.
Results demonstrated several differences between CAVHD and con-
ventional hemodialysis and hemodiafiltration. First, dialysate flow rate
(10 to 20 mI/mm) is very low compared to blood flow rate (100 to 150
mI/mm), and as a consequence the change in blood and dialysate solute
concentrations over the length of the filter cannot be taken to be linear.
Second, due to the interaction of convection and diffusion, the diffusive
mass transfer coefficient, Kd, depends on filtrate and dialysate flow
rates. Third, due to the longer use of the filter, both clotting and the
formation of a protein boundary layer limit the maximal Kd that may be
obtained. The model has proved useful for analyzing the impact of
several factors on filter performance and for oredicting solute clearance
under specific clinical conditions.
Randomized conversion of cyclosporine to conventional therapy at 3
months after renal transplantation: Four year results. A.M.M. Kootte,
L.A. van Es, L.C. Paul, Department of Nephrology, University Hos-
pital, Leiden, The Netherlands. The results of 40 cadaveric renal
transplant patients who were randomly assigned to conversion of
cyclosporin A (CsA) to azathioprine (Aza) at 3 months post-transplant
were compared with those of 40 patients who remained on CsA therapy;
all patients had received pre-transplant blood transfusions and were on
low doses of prednisone. The start point of the study was at 3 months
post-transplant. The 4-year patient and graft survival were 95% and
90% in the converted and 90% and 77.5% in the non-converted group,
respectively. In the converted group 15% of the patients experienced
one or more rejection episodes between 3 and 12 months and 9%
between 12 and 48 months compared with 13% and 5% in the CsA
group. The hypertension incidence was 78 to 95% in the CsA group at
different time intervals compared with 54 to 59% in the converted
group. At 4 years, the mean creatinine clearance for the converted
patients was 78 8 mI/mm compared with 58 5 mI/mm in the CsA
group. This study shows that elective CsA conversion is a safe
procedure which may be cost effective and gives a superior graft
function and less hypertension at 4 years.
Prevention of fatal cytomegalovirus disease by passive immunization in
kidney transplant recipients treated for rejection. H.J. Metselaar, P.H.
Rothbarth, R.M.L. Brouwer, G.J. Wenting, W. Weimar, Departments
of Internal Medicine and Virology, University Hospital, Rotterdam,
The Netherlands. The incidence of cytomegalovirus (CMV) disease is
high in kidney transplant recipients treated for rejection. Prevention or
mitigation of this potentially lethal complication is therefore important.
Passive immunization with anti-CMV immunoglobulmns has been sub-ject of several studies but still remains a controversial issue. The
drawback of most studies is that not all treated patients run the same
risk for acquiring CMV disease. Here we report the results of the first
double blind, placebo controlled trial on the value of passive immuni-
zation in kidney transplant recipients treated for rejection with rabbit
ATG. Forty patients were randomized to receive either anti-CMV
immunoglobulin or albumin in a dose of 100 mg/kg body weight.
Globulin/albumin infusions were given on the day of ATG treatment
and on days 7, 14, 35, 56 and 77 thereafter. Before each infusion
samples of urine, throat wash and peripheral blood leukocytes were
collected for virus isolation. Before transplantation donor and recipient
sera were screened for lgG antibody against CMV with an ELISA.
Symptomatic CMV disease had to be confirmed with concomitant virus
isolation. Between the globulin and placebo treated groups at risk no
significant difference in incidence of CMV isolation (94 vs. 73%),
viremia (69 vs. 53%) or disease (44 vs. 40%) was observed. However,
none of the globulin treated patients died from CMV disease, in contrast
to 4 in the placebo treated group. This difference was statistically
significant different in the 19 patients with viremia (difference 50%, 95%
Cl 13 to 87%, P < 0.05). Lethal CMV disease was exclusively seen in
CMV seronegative recipients of seropositive allograft donors. Passive
immunization completely prevented fatal CMV disease, although it did
not reduce the number of patients with positive CMV isolation or
disease. The beneficial effect of immunoprophylaxis was only found in
the CMV seronegative recipients of a seropositive kidney.
Albuminui-ia In murine graft versus host nephritis is not dependent on
late complement factors. R.F.M. Rombouts, K.J.M. Assmann, J.P.H.F.
van Son, H.B.P.M. D,jkman, R.A.P. Koene, Departments of Pathol-
ogy and Nephrology, University Hospital, Njjmegen, The Netherlands.
Graft versus host disease, which is induced by the injection of parental
strain lymphocytes into Fl hybrid mice, is accompanied by a membra-
nous glomerulonephritis and a nephrotic syndrome in certain Fl com-
binations. To study whether late complement (C) factors participate in
the induction of albuminuria in this model, we injected 17 female (A.TH
x A.TL) Fl hybrids iv. at days I and 5 with 1.8 x 108 A.TH donor
lymphocytes obtained from spleen, thymus, and abdominal lymph
nodes. Both mouse strains are congenitally deficient of CS and did not
show measurable complement activity in a hemolytic micro-assay of
mouse C. Ten non-injected hybrids served as controls. At week 12,
when the mice were killed, all the injected mice had developed
albuminuria (5396 1852 jig of albumin/l8 hr; mean SEM) while the
control mice excreted normal amounts of albumin (<75 jsg/18 hr). By
light microscopy, no glomerular proliferation was seen; some mice had
developed occasional spikes on the subepithelial side of the GBM. By
immunofluorescence glomeruli of the albuminuric mice showed linear
and/or granular staining of mouse IgG. In 15 of 17 mice there was also
staining of C3 along the glomerular capillary wall. Mice with granular
deposits of mouse lgG and C3 had typical subepithelial electron-dense
deposits in EM. These results demonstrate that typical lesions of
membranous glomerulonephritis accompanied by substantial albumin-
uria can be induced in CS deficient mice in which activation of late C
factors, that is, the membrane attack complex, cannot occur. It is
questionable whether activation of early C components is involved
since some mice had clearcut albuminuria in the absence of glomerular
C3 deposits.
Immune response to influenza vaccination in primary IgA nephrop-
athy. A. W.L. van den Wall Bake, W.E.P. Beyer, J.H. Evers-Schouten,
M.R. Daha, N. Masurel, L.A. van Es, Department of Nephroiogy,
University Hospital Leiden, and Department of Virology and WHO
Influenza Centre, Erasmus University Rotterdam, The Netherlands.
Primary IgA nephropathy (IgAN) is characterized by mesangial depos-
its of IgA1, increased serum IgA1 concentrations and circulating IgA1
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containing immune complexes. To investigate whether IgAN patients
manifest an IgA hyperresponsiveness, limited to the subclass IgA1, we
studied the serum anti-influenza antibodies after intramuscular vacci-
nation with inactivated influenza virus in 18 patients and 22 healthy
controls. Anti-influenza antibodies were measured with an isotype-
specific enzyme immunoassay before vaccination, and at weekly inter-
vals thereafter for a period of 5 weeks. The size of the influenza-specific
antibodies of the IgA and IgA1 isotypes was determined by high
performance liquid chromatography of sera obtained on days 14 and 28.
Data were analyzed by two-way analysis of variance. Patients with
IgAN had a significantly higher anti-influenza response in the IgA1
isotype (P < 0.0001), but not in the isotypes IgG, 1gM, and IgA2. The
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total IgA immune response was higher in the patient group, but this
difference was of marginal statistical significance (P = 0.058). The ratio
of IgA antibodies to the sum of IgA, IgG, and 1gM antibodies was
significantly (P = 0.039) higher in patients. Within the IgA class, the
ratio of lgA1 to IgA1 plus lgA2 antibodies was also significantly (P <
0.0001) higher in patients. Patients produced significantly (P = 0.035)
more monomeric IgA1 antibodies than controls, and the ratio of
polymeric to total IgA and LgA1 antibodies was similar in both groups.
These data indicate that IgAN patients have a hyperresponsiveness
limited to the subclass IgA1, mainly expressed by an excess of mono-
mers. An as yet unidentified abnormality of immune regulation proba-
bly causes this hyperresponsiveness.
